Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New data highlight how Heartflow's AI software drives major shifts in heart care
One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.
First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve
A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.
AHA data challenge explores links between inflammation and heart disease
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others.
FDA recalls real-time glucose monitors after 56 injuries
Receivers on active glucose monitors manufactured by Dexcom are reportedly failing to send alerts when a patient’s blood sugar levels are dangerously high or low. There have been no deaths linked to the malfunction.
What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis
President Donald Trump has been diagnosed with chronic venous insufficiency. He underwent a complete evaluation due to swelling in his legs, the White House announced, and is in “excellent health” otherwise.

LAAO with Watchman device consistently lowers stroke risk after 1 year

After one year, the stroke rate for LAAO patients was just 1.53%.

When STEMI patients present late, immediate and delayed PCI lead to similar outcomes

Exploring data from nearly 6,000 STEMI patients, the study's authors aimed to learn more about the impact of immediate vs. delayed PCI.

Apixaban appears safe for most TAVR patients, but questions remain

Researchers tracked data from more than 1,500 patients who underwent a successful TAVR procedure from 2016 to 2019.

Elective revascularization with PCI or CABG provides long-term cardiovascular benefits, new meta-analysis confirms

Researchers evaluated data from 25 different randomized clinical trials, sharing their findings virtually at EuroPCR 2021.

Dapagliflozin fails to reduce the risk of organ failure or death among COVID-19 patients

Patients given the SGLT2 inhibitor did experience improved outcomes, the researchers noted, but none of the differences were statistically significant.

A milestone for Medtronic: Low-risk TAVR patients treated with Evolut ‘doing exceptionally well’ after 2 years

The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients.

Abbott’s new self-expanding TAVR system gains CE mark approval

The solution has still only been approved in the United States for investigational use.

Finerenone limits AFib in patients with chronic kidney disease, Type 2 diabetes

This secondary analysis of data from the FIDELIO-DKD trial was presented May 17 at ACC.21 and published in the Journal of the American College of Cardiology.

Clinical

New data highlight how Heartflow's AI software drives major shifts in heart care

First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve

AHA data challenge explores links between inflammation and heart disease

FDA recalls real-time glucose monitors after 56 injuries

What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis